As 23andMe files for bankruptcy and Wojcicki steps down as CEO (so she can bid) Anya Prince & my recent JAMA piece discusses what can - and should - happen to the over 1 million private genomes it has collected
Reposted from
JAMA
Many who undergo direct-to-consumer genetic testing don’t realize that their data are being licensed to pharmaceutical and biotech companies.
JAMA Viewpoint authors @kaytesb.bsky.social and Anya E. R. Prince discuss this gap between consumer expectations and what is being done.
ja.ma/40uGL7q
JAMA Viewpoint authors @kaytesb.bsky.social and Anya E. R. Prince discuss this gap between consumer expectations and what is being done.
ja.ma/40uGL7q
Comments